|
Market Closed -
NSE India S.E.
07:05:07 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 1,386.10 INR | -0.60% |
|
+1.47% | -8.28% |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
Chart: Technical Analysis
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| CIPLA | Delayed | |
Bombay S.E.
| CIPLA | Delayed | |
LUXEMBOURG S.E.
| CIPLA | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 1,402.7 | 1,477 | 1,584.4 |
| Spread/Res. | -1.18% | -6.15% | -12.52% |
| Spread/Supp. | +2.61% | +2.61% | +16.24% |
| Support | 1,350.8 | 1,350.8 | 1,192.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
